Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FXMG2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,695
Award facts
- Contract value 100% obligated
- $18,695.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,695.23 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL configuration. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 3, 2025, issued on September 2, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and other government healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. As a competitively awarded prime contractor, AmerisourceBergen demonstrates significant capability in fulfilling federal medical supply requirements, with delivery orders under this vehicle ranging substantially in value and covering multiple therapeutic domains including specialty medications and biologics such as Cosentyx used for treating inflammatory conditions.
Quick answers
Who was awarded contract SPE2DB25FXMG2?
SPE2DB25FXMG2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FXMG2 worth?
The government has obligated $18,695 on SPE2DB25FXMG2.
Is contract SPE2DB25FXMG2 an order under another contract?
Yes. SPE2DB25FXMG2 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXMG2 competed?
The extent of competition for SPE2DB25FXMG2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award